BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30314605)

  • 1. Structural MRI in Idiopathic Parkinson's Disease.
    De Micco R; Russo A; Tessitore A
    Int Rev Neurobiol; 2018; 141():405-438. PubMed ID: 30314605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered functional connectivity in the default mode network is associated with cognitive impairment and brain anatomical changes in Parkinson's disease.
    Lucas-Jiménez O; Ojeda N; Peña J; Díez-Cirarda M; Cabrera-Zubizarreta A; Gómez-Esteban JC; Gómez-Beldarrain MÁ; Ibarretxe-Bilbao N
    Parkinsonism Relat Disord; 2016 Dec; 33():58-64. PubMed ID: 27659747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
    Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
    BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistically Defined Parkinson's Disease Executive and Memory Cognitive Phenotypes: Demographic, Behavioral, and Structural Neuroimaging Comparisons.
    Crowley SJ; Banan G; Amin M; Tanner JJ; Hizel L; Nguyen P; Brumback B; Rodriguez K; McFarland N; Bowers D; Ding M; Mareci TA; Price CC
    J Parkinsons Dis; 2021; 11(1):283-297. PubMed ID: 33216042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical gray and subcortical white matter associations in Parkinson's disease.
    Sterling NW; Du G; Lewis MM; Swavely S; Kong L; Styner M; Huang X
    Neurobiol Aging; 2017 Jan; 49():100-108. PubMed ID: 27776262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease.
    Surova Y; Lampinen B; Nilsson M; Lätt J; Hall S; Widner H; ; van Westen D; Hansson O
    PLoS One; 2016; 11(6):e0157755. PubMed ID: 27362763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural and dopaminergic correlates of fatigue in Parkinson's disease.
    Kang SY; Bang M; Hong JY; Oh J; Kim JS; Han YM; Chang SK; Lee SA; Yoon U; Shin NY
    J Neural Transm (Vienna); 2020 Mar; 127(3):301-309. PubMed ID: 31894419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature.
    Sarasso E; Agosta F; Piramide N; Filippi M
    J Neurol; 2021 Sep; 268(9):3144-3179. PubMed ID: 32378035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of diffusion kurtosis changes in Parkinson's disease subtypes.
    Sejnoha Minsterova A; Klobusiakova P; Pies A; Galaz Z; Mekyska J; Novakova L; Nemcova Elfmarkova N; Rektorova I
    Parkinsonism Relat Disord; 2020 Dec; 81():96-102. PubMed ID: 33120076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in functional organization and white matter integrity in the connectome in Parkinson's disease.
    Tinaz S; Lauro PM; Ghosh P; Lungu C; Horovitz SG
    Neuroimage Clin; 2017; 13():395-404. PubMed ID: 28116232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Brain Alterations in Motor Subtypes of Parkinson's Disease: Evidence from Probabilistic Tractography and Shape Analysis.
    Vervoort G; Leunissen I; Firbank M; Heremans E; Nackaerts E; Vandenberghe W; Nieuwboer A
    PLoS One; 2016; 11(6):e0157743. PubMed ID: 27314952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural Correlates of Cognitive Impairment in Parkinson's Disease: A Review of Structural MRI Findings.
    Hall JM; Lewis SJG
    Int Rev Neurobiol; 2019; 144():1-28. PubMed ID: 30638452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and structural changes in gray matter of parkinson's disease patients with mild cognitive impairment.
    Chen B; Wang S; Sun W; Shang X; Liu H; Liu G; Gao J; Fan G
    Eur J Radiol; 2017 Aug; 93():16-23. PubMed ID: 28668411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
    J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considering total intracranial volume and other nuisance variables in brain voxel based morphometry in idiopathic PD.
    Crowley S; Huang H; Tanner J; Zhao Q; Schwab NA; Hizel L; Ramon D; Brumback B; Ding M; Price CC
    Brain Imaging Behav; 2018 Feb; 12(1):1-12. PubMed ID: 28070745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's Disease Risk Variant rs9638616 is Non-Specifically Associated with Altered Brain Structure and Function.
    Welton T; Teo TWJ; Chan LL; Tan EK; Tan LCS
    J Parkinsons Dis; 2024; 14(4):713-724. PubMed ID: 38640170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A
    Waggan I; Rissanen E; Tuisku J; Matilainen M; Parkkola R; Rinne JO; Airas L
    Parkinsonism Relat Disord; 2023 Aug; 113():105766. PubMed ID: 37480614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter microstructure damage in tremor-dominant Parkinson's disease patients.
    Luo C; Song W; Chen Q; Yang J; Gong Q; Shang HF
    Neuroradiology; 2017 Jul; 59(7):691-698. PubMed ID: 28540401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Educational attainment and motor burden in Parkinson's disease.
    Kotagal V; Bohnen NI; Müller ML; Koeppe RA; Frey KA; Langa KM; Albin RL
    Mov Disord; 2015 Jul; 30(8):1143-7. PubMed ID: 26096339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different covariates and contrasts on classification of Parkinson's disease using structural MRI.
    Cigdem O; Beheshti I; Demirel H
    Comput Biol Med; 2018 Aug; 99():173-181. PubMed ID: 29935389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.